Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzyme Catalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel mutant enzyme method for PLP production ensures high purity and supply stability for global pharmaceutical and nutrition manufacturers seeking reliable partners.
Patent CN116875575A reveals mutant enzyme for L-glufosinate. Achieves 99% conversion in 4h. Offers cost reduction and supply chain reliability for agrochemical manufacturing.
Patent CN111321178B reveals a high-yield enzymatic route for L-2-aminobutanamide. Discover cost-effective manufacturing and supply chain advantages for API intermediates.
Patent CN111235084A reveals a cost-effective enzymatic route for S-adenosylmethionine using recombinant E. coli, offering significant supply chain advantages.
Patent CN104480100A reveals immobilized enzyme method for L-tert-leucine. Offers high conversion, enzyme reuse, and cost reduction for pharmaceutical supply chains.
Patent CN113717910B details a novel tri-enzyme system for (S)-citronellol synthesis, offering superior selectivity and scalable production for the global fragrance industry.
Patent CN115975969A discloses high-efficiency transaminase mutants for Sitagliptin synthesis, offering superior conversion rates and stability for cost reduction in API manufacturing.
Patent CN118389613A reveals high-yield hydroxytyrosol synthesis. Offers cost reduction and supply chain reliability for food and pharma industries.
Patent CN101565685A reveals a novel recombinant E. coli strain for producing chiral acetoin and 2,3-butanediol with high ee values, offering significant cost reduction in chiral chemical manufacturing.
Patent CN106480157A details ionic liquid enzyme method for high-purity rare ginsenosides, ensuring scalable supply chain solutions.
Patent CN105624128B reveals a robust immobilized enzyme process for synthesizing key HCV drug intermediates, offering superior stability and cost efficiency.
Patent CN104480181B reveals enzymatic D-7-ACA synthesis. High purity and yield offer supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN117757876A reveals double-enzyme catalysis for 2'-F-dAR. Offers simplified process, cost reduction in pharmaceutical intermediates manufacturing, and high purity.
Novel immobilized enzyme method for ATP synthesis ensures stable quality and cost efficiency. Ideal for pharmaceutical intermediates supply chain optimization and large scale production.
Patent CN120555388A reveals enhanced leucine dehydrogenase mutants for high-purity L-phenylglycine synthesis, offering significant supply chain and cost advantages.
Novel enzyme-chemical hybrid process ensures high purity trans-tranexamic acid with reduced environmental impact and scalable manufacturing capabilities for global supply chains.
Patent CN116790527B reveals dual-enzyme catalysis for high-purity 25-Hydroxyvitamin D3. Achieve cost reduction and scalable supply chain reliability.
Patent CN104480181A reveals enzymatic D-7-ACA synthesis offering high purity and yield. This process enables cost reduction in pharmaceutical intermediates manufacturing and supply chain stability.
Patent CN118895266A reveals enzymatic synthesis of L-2-aminobutyric acid. Achieve >99% conversion with reduced environmental impact for levetiracetam production.
Patent CN118879653A reveals high-efficiency DAAO mutant for L-glufosinate production. Achieves 99% conversion with reduced costs and enhanced supply chain reliability for global agrochemical manufacturers.